Document resource
Experts warn that the much heralded US-UK trade deal on pharmaceuticals will be an “absolute catastrophe” for NHS patients and will widen health inequalities. Jacqui Wise reports
Annotated abstract
Is the NHS the main loser in the US-UK drug agreement?
bmj · 2025-12-23 · canonical JSON source